Colistin Heteroresistance in Multidrug-Resistant Gram-Negative Bacilli
Phenotypic and Genotypic Detection of Colistin Heteroresistance Among Multidrug-Resistant Gram-Negative Bacilli in Assiut University Hospitals
This cross-sectional study aims to detect colistin heteroresistance phenotypically and genotypically among multidrug-resistant Gram-negative bacilli isolated from clinical specimens at Assiut University Hospitals.
研究概览
地位
地位
详细说明
Multidrug-resistant Gram-negative bacterial infections are a major clinical concern. Colistin is used as a last-line therapy, but heteroresistance (presence of resistant subpopulations within a susceptible isolate) may lead to treatment failure and is difficult to detect by routine methods.
This observational study will collect multidrug-resistant Gram-negative isolates that are intermediate to colistin by broth microdilution and will test them for heteroresistance using population analysis profile as the reference method, in addition to gradient strips (Etest) and disc diffusion. Molecular detection of related resistance genes will also be performed.
研究类型
研究类型
注册 (估计的)
注册
联系人和位置
学习联系方式
学习联系方式
- 姓名:Aliaa A Abdelrahman, Resident
- 电话号码:01064480804
- 邮箱:Aliaa.14223941@med.aun.edu.eg
参与标准
资格标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Multidrug-resistant Gram-negative bacterial isolates obtained from clinical specimens of hospitalized patients at Assiut University Hospitals.
描述
Inclusion Criteria:
- - Multidrug-resistant Gram-negative isolates from clinical specimens
- Colistin intermediate confirmed by broth microdilution
Exclusion Criteria:
- Gram-positive bacteria
- Carbapenem-sensitive Gram-negative bacteria
- Repeated samples from the same patient
- Colistin-resistant isolates confirmed by broth microdilution
学习计划
研究是如何设计的?
设计细节
- 观测模型:CASE_ONLY
- 时间观点:CROSS_SECTIONAL
团体/队列数
队列和干预
团体/队列团体/队列 |
|---|
|
Multidrug-Resistant Gram-Negative Isolates
Clinical isolates of multidrug-resistant Gram-negative bacilli that are intermediate to colistin and will be tested for heteroresistance. |
研究衡量的是什么?
主要结果指标
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of isolates with colistin heteroresistance
大体时间:Baseline
|
Number of multidrug-resistant Gram-negative isolates showing colistin heteroresistance by population analysis profile test. |
Baseline
|
次要结果测量
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of isolates positive by Etest
大体时间:Baseline
|
Number of isolates showing colistin heteroresistance by gradient strip (Etest) method. |
Baseline
|
|
Number of isolates positive by disc diffusion
大体时间:Baseline
|
Number of isolates showing colistin heteroresistance by disc diffusion method. |
Baseline
|
|
Number of isolates carrying colistin heteroresistance-related genes
大体时间:Baseline
|
Number of isolates positive for genes associated with colistin heteroresistance detected by conventional polymerase chain reaction. |
Baseline
|
合作者和调查者
调查人员
调查人员
- 学习椅:Mohamed Z Abdel-rahman, prof、Clinical pathology Department, Assiut University Hospitals
- 学习椅:Marwa M Mohammed, prof、Clinical pathology Department, Assiut University Hospitals
研究记录日期
研究主要日期
学习开始 (估计的)
学习开始
初级完成 (估计的)
初级完成
研究完成 (估计的)
研究完成
研究注册日期
首次提交
首次提交
首先提交符合 QC 标准的
首先提交符合 QC 标准的
首次发布 (实际的)
首次发布
研究记录更新
最后更新发布 (实际的)
最后更新发布
上次提交的符合 QC 标准的更新
上次提交的符合 QC 标准的更新
最后验证
最后验证
更多信息
与本研究相关的术语
其他研究编号
其他研究编号
- Colistin-Heteroresistance-26
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.